Market Research Logo

Global Tyrosine Kinase JAK Inhibitors Market Research Report 2018

Global Tyrosine Kinase JAK Inhibitors Market Research Report 2018

This report studies the Tyrosine Kinase JAK Inhibitors market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Tyrosine Kinase JAK Inhibitors market by product type and applications/end industries.

The major players in global Tyrosine Kinase JAK Inhibitors market include
Pfizer
Incyte
Novartis
Eli Lilly
Gilead
Sanofi
Galapagos
AbbVie
Vertex
Teva
Astellas Pharma
Celgene
CTI BioPharma

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth rate of Tyrosine Kinase JAK Inhibitors in these regions, from 2012 to 2023 (forecast), covering
North America
Europe
Japan
RoW

On the basis of product, the Tyrosine Kinase JAK Inhibitors market is primarily split into
Tofacitinib
Ruxolitinib
Baricitinib

On the basis on the end users/applications, this report covers
Rheumatoid Arthritis (RA)
Polycythemia Vera (PCV)
Myelofibrosis (MF)
Others


1 Tyrosine Kinase JAK Inhibitors Market Overview
1.1 Tyrosine Kinase JAK Inhibitors Product Overview
1.2 Tyrosine Kinase JAK Inhibitors Segment by Types (Product Category)
1.2.1 Global Tyrosine Kinase JAK Inhibitors Sales and Growth Rate Comparison by Types (2012-2023)
1.2.2 Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Types in 2017
1.2.3 Tofacitinib
1.2.4 Ruxolitinib
1.2.5 Baricitinib
1.3 Global Tyrosine Kinase JAK Inhibitors Segment by Applications
1.3.1 Global Tyrosine Kinase JAK Inhibitors Sales Comparison by Applications (2012-2023)
1.3.2 Rheumatoid Arthritis (RA)
1.3.3 Polycythemia Vera (PCV)
1.3.4 Myelofibrosis (MF)
1.4 Global Tyrosine Kinase JAK Inhibitors Market by Regions (2012-2023)
1.4.1 Global Tyrosine Kinase JAK Inhibitors Market Size and Growth Rate Comparison by Regions (2012-2023)
1.4.2 North America Tyrosine Kinase JAK Inhibitors Status and Prospect (2012-2023)
1.4.3 Europe Tyrosine Kinase JAK Inhibitors Status and Prospect (2012-2023)
1.4.4 Japan Tyrosine Kinase JAK Inhibitors Status and Prospect (2012-2023)
1.4.5 RoW Tyrosine Kinase JAK Inhibitors Status and Prospect (2012-2023)
1.5 Global Tyrosine Kinase JAK Inhibitors Market Size (2012-2023)
1.5.1 Global Tyrosine Kinase JAK Inhibitors Revenue Status and Outlook (2012-2023)
1.5.2 Global Tyrosine Kinase JAK Inhibitors Sales Status and Outlook (2012-2023)
2 Global Tyrosine Kinase JAK Inhibitors Market Competition by Manufacturers/Brand
2.1 Global Tyrosine Kinase JAK Inhibitors Sales and Share by Manufacturers
2.2 Global Tyrosine Kinase JAK Inhibitors Revenue and Share by Manufacturers (2016-2017)
2.3 Global Tyrosine Kinase JAK Inhibitors Average Price by Manufacturers (2016-2017)
2.4 Manufacturers Tyrosine Kinase JAK Inhibitors Headquarters, Established Date and Product Types
2.5 Tyrosine Kinase JAK Inhibitors Market Competitive Situation and Trends
2.5.1 Tyrosine Kinase JAK Inhibitors Market Concentration Rate
2.5.2 Tyrosine Kinase JAK Inhibitors Revenue Market Share of Top 3 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Tyrosine Kinase JAK Inhibitors Sales, Revenue by Regions (2012-2017)
3.1 Global Tyrosine Kinase JAK Inhibitors Sales and Market Share by Regions (2012-2017)
3.2 Global Tyrosine Kinase JAK Inhibitors Revenue and Market Share by Regions (2012-2017)
3.3 Global Tyrosine Kinase JAK Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
3.4 North America Tyrosine Kinase JAK Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
3.5 Europe Tyrosine Kinase JAK Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
3.6 Japan Tyrosine Kinase JAK Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
3.7 RoW Tyrosine Kinase JAK Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
4 Global Tyrosine Kinase JAK Inhibitors Sales, Revenue, Price Trend by Types
4.1 Global Tyrosine Kinase JAK Inhibitors Sales and Market Share by Types (2012-2017)
4.2 Global Tyrosine Kinase JAK Inhibitors Revenue and Market Share by Types (2012-2017)
4.3 Global Tyrosine Kinase JAK Inhibitors Price by Type (2012-2017)
4.4 Global Tyrosine Kinase JAK Inhibitors Sales Growth by Type (2012-2017)
5 Global Tyrosine Kinase JAK Inhibitors Market Analysis by Applications
5.1 Global Tyrosine Kinase JAK Inhibitors Sales and Market Share by Applications (2012-2017)
5.2 Global Tyrosine Kinase JAK Inhibitors Sales Growth Rate by Applications (2012-2017)
6 Analysis of Tyrosine Kinase JAK Inhibitors Industry Key Manufacturers
6.1 Pfizer
6.1.1 Company Profile
6.1.2 Product Information
6.1.3 Sales, Price, Cost, Gross, and Revenue
6.2 Incyte
6.2.1 Company Profile
6.2.2 Product Information
6.2.3 Sales, Price, Cost, Gross, and Revenue
6.3 Novartis
6.3.1 Company Profile
6.3.2 Product Information
6.3.3 Sales, Price, Cost, Gross, and Revenue
6.4 Eli Lilly
6.4.1 Company Profile
6.4.2 Product Information
6.4.3 Sales, Price, Cost, Gross, and Revenue
6.5 Other Tyrosine Kinase JAK Inhibitors Industry Key Players
6.5.1 Gilead
6.5.2 Sanofi
6.5.3 Galapagos
6.5.4 AbbVie
6.5.5 Vertex
6.5.6 Teva
6.5.7 Astellas Pharma
6.5.8 Celgene
6.5.9 CTI BioPharma
6.5.10 Pfizer
6.5.11 Eli Lilly
7 Tyrosine Kinase JAK Inhibitors Manufacturing Cost Analysis
7.1 Tyrosine Kinase JAK Inhibitors Drugs R&D Cost Analysis
8.1.1 Clinical Phase Costs
8.1.2 Capitalized Costs
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost Analysis
7.2.2.1 USA Labor Cost Analysis
7.2.2.2 Europe Labor Costs Analysis
7.2.2.3 Asia Labor Costs Analysis
7.2.3 Other Costs Analysis
7.2.3.1 USA Cost of Electricity Analysis
7.2.3.2 USA Water Cost Analysis
7.2.3.3 Europe Cost of Electricity Analysis
7.2.3.4 Europe Water Cost Analysis
7.2.3.5 China Cost of Electricity Analysis
7.2.3.6 China Water Cost Analysis
7.2.4 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Tyrosine Kinase JAK Inhibitors
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Tyrosine Kinase JAK Inhibitors Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress
10.1.1 Introduction to JAK-STAT Signaling
10.1.2 Janus Kinase Biochemistry
10.1.3 Selected Janus Kinase Disease Targets
10.1.4 Selected Janus Kinase Inhibitors in Clinical Trials
10.1.4.1 First-generation Drugs
10.1.4.2 Second-generation Drugs
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 Global Tyrosine Kinase JAK Inhibitors Market Forecast (2018-2023)
11.1 Global Tyrosine Kinase JAK Inhibitors Sales, Revenue Forecast (2018-2023)
11.1.1 Global Tyrosine Kinase JAK Inhibitors Sales and Growth Rate Forecast (2018-2023)
11.1.2 Global Tyrosine Kinase JAK Inhibitors Revenue and Growth Rate Forecast (2018-2023)
11.1.3 Global Tyrosine Kinase JAK Inhibitors Price and Trend Forecast (2018-2023)
11.2 Global Tyrosine Kinase JAK Inhibitors Sales and Revenue Forecast by Regions (2018-2023)
11.2.1 North America Tyrosine Kinase JAK Inhibitors Sales and Revenue Forecast (2018-2023)
11.2.2 Europe Tyrosine Kinase JAK Inhibitors Sales and Revenue Forecast (2018-2023)
11.2.3 Japan Tyrosine Kinase JAK Inhibitors Sales and Revenue Forecast (2018-2023)
11.2.4 RoW Tyrosine Kinase JAK Inhibitors Sales and Revenue Forecast (2018-2023)
11.3 Global Tyrosine Kinase JAK Inhibitors Sales, Revenue, Price Forecast by Type (2018-2023)
11.4 Global Tyrosine Kinase JAK Inhibitors Sales Forecast by Application (2018-2023)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures
Figure Product Picture of Tyrosine Kinase JAK Inhibitors
Table Classification of Tyrosine Kinase JAK Inhibitors
Figure Global Tyrosine Kinase JAK Inhibitors Sales (K Unit) Comparison by Types (Product Category) (2012-2023)
Figure Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Types in 2017
Figure Product Picture of Tofacitinib
Figure Product Picture of Ruxolitinib
Figure Product Picture of Baricitinib
Table Application of Tyrosine Kinase JAK Inhibitors
Figure Global Tyrosine Kinase JAK Inhibitors Sales (K Unit) Comparison by Applications (2012-2023)
Figure Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Applications in 2017
Figure Rheumatoid Arthritis (RA) Examples
Figure Polycythemia Vera (PCV) Examples
Figure Myelofibrosis (MF) Examples
Figure Global Tyrosine Kinase JAK Inhibitors Market Size Comparison and Growth Rate by Regions (2012-2023)
Table Global Market Tyrosine Kinase JAK Inhibitors Revenue (M USD) Comparison by Regions 2012-2023
Figure North America Tyrosine Kinase JAK Inhibitors Revenue (M USD) and Growth Rate (2012-2023)
Figure Europe Tyrosine Kinase JAK Inhibitors Revenue (M USD) and Growth Rate (2012-2023)
Figure Japan Tyrosine Kinase JAK Inhibitors Revenue (M USD) and Growth Rate (2012-2023)
Figure RoW Tyrosine Kinase JAK Inhibitors Revenue (M USD) and Growth Rate (2012-2023)
Figure Global Tyrosine Kinase JAK Inhibitors Revenue (M USD) Status and Outlook (2012-2023)
Figure Global Tyrosine Kinase JAK Inhibitors Sales (K Unit) Status and Outlook (2012-2023)
Table Global Tyrosine Kinase JAK Inhibitors Sales (K Unit) of Key Manufacturers (2016-2017)
Table Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Manufacturers (2016-2017)
Figure 2016 Tyrosine Kinase JAK Inhibitors Sales Market Share by Manufacturers
Figure 2017 Tyrosine Kinase JAK Inhibitors Sales Market Share by Manufacturers
Table Global Tyrosine Kinase JAK Inhibitors Revenue (M USD) by Manufacturers (2016-2017)
Table Global Tyrosine Kinase JAK Inhibitors Revenue Market Share by Manufacturers (2016-2017)
Table 2016 Global Tyrosine Kinase JAK Inhibitors Revenue Market Share by Manufacturers
Table 2017 Global Tyrosine Kinase JAK Inhibitors Revenue Market Share by Manufacturers
Table Global Market Tyrosine Kinase JAK Inhibitors Average Price (USD/Unit) of Key Manufacturers (2016-2017)
Figure Global Market Tyrosine Kinase JAK Inhibitors Average Price (USD/Unit) of Key Manufacturers in 2016
Figure Global Market Tyrosine Kinase JAK Inhibitors Average Price (USD/Unit) of Key Manufacturers in 2017
Table Manufacturers Tyrosine Kinase JAK Inhibitors Headquarters and Established Date
Table Manufacturers Tyrosine Kinase JAK Inhibitors Product Category
Figure Tyrosine Kinase JAK Inhibitors Sales Market Concentration Rate in 2016
Figure Tyrosine Kinase JAK Inhibitors Revenue Market Share of Top 3 Manufacturers in 2016
Table Mergers & Acquisitions, Expansion
Table Global Tyrosine Kinase JAK Inhibitors Sales (K Unit) by Regions (2012-2017)
Table Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Regions (2012-2017)
Figure Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Regions (2012-2017)
Figure 2016 Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Regions
Table Global Tyrosine Kinase JAK Inhibitors Revenue (M USD) by Regions (2012-2017)
Table Global Tyrosine Kinase JAK Inhibitors Revenue Market Share by Regions (2012-2017)
Figure Global Tyrosine Kinase JAK Inhibitors Revenue Market Share by Regions (2012-2017)
Figure 2016 Global Tyrosine Kinase JAK Inhibitors Revenue Market Share by Regions
Table Global Tyrosine Kinase JAK Inhibitors Sales (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America Tyrosine Kinase JAK Inhibitors Sales (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe Tyrosine Kinase JAK Inhibitors Sales (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan Tyrosine Kinase JAK Inhibitors Sales (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table RoW Tyrosine Kinase JAK Inhibitors Sales (K Unit), Revenue (M USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global Tyrosine Kinase JAK Inhibitors Sales (K Unit) by Types (2012-2017)
Table Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Types (2012-2017)
Figure Sales Market Share of Tyrosine Kinase JAK Inhibitors by Types (2012-2017)
Figure 2017 Sales Market Share of Tyrosine Kinase JAK Inhibitors by Types
Table Global Tyrosine Kinase JAK Inhibitors Revenue (M USD) by Types (2012-2017)
Table Global Tyrosine Kinase JAK Inhibitors Revenue Market Share by Types (2012-2017)
Figure Revenue Market Share of Tyrosine Kinase JAK Inhibitors by Types (2012-2017)
Figure 2017 Revenue Market Share of Tyrosine Kinase JAK Inhibitors by Types
Table Global Tyrosine Kinase JAK Inhibitors Price (USD/Unit) by Types (2012-2017)
Figure Global Tyrosine Kinase JAK Inhibitors Sales Growth Rate by Type (2012-2017)
Table Global Tyrosine Kinase JAK Inhibitors Sales (K Unit) by Applications (2012-2017)
Table Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Applications (2012-2017)
Figure Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Applications (2012-2017)
Figure Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Applications in 2017
Table Global Tyrosine Kinase JAK Inhibitors Sales Growth Rate by Applications (2012-2017)
Figure Global Tyrosine Kinase JAK Inhibitors Sales Growth Rate by Applications (2012-2017)
Table Pfizer Company Profile
Figure Tyrosine Kinase JAK Inhibitors Product Information of Pfizer
Table Tyrosine Kinase JAK Inhibitors Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer (2016 and 2017)
Table Incyte Company Profile
Figure Tyrosine Kinase JAK Inhibitors Product Information of Incyte
Table Tyrosine Kinase JAK Inhibitors Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Incyte (2016 and 2017)
Table Novartis Company Profile
Figure Tyrosine Kinase JAK Inhibitors Product Information of Novartis
Table Tyrosine Kinase JAK Inhibitors Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Novartis (2016 and 2017)
Table Eli Lilly Company Profile
Figure Tyrosine Kinase JAK Inhibitors Product Information of Eli Lilly
Table Tyrosine Kinase JAK Inhibitors Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Eli Lilly (2016 and 2017)
Table Gilead Company Profile
Table Tyrosine Kinase JAK Inhibitors Product Information of Gilead
Table Sanofi Company Profile
Table Tyrosine Kinase JAK Inhibitors Product Information of Sanofi
Table Galapagos Company Profile
Table Tyrosine Kinase JAK Inhibitors Product Information of Galapagos
Table AbbVie Company Profile
Table Tyrosine Kinase JAK Inhibitors Product Information of AbbVie
Table Vertex Company Profile
Table Tyrosine Kinase JAK Inhibitors Product Information of Vertex
Table Teva Company Profile
Table Tyrosine Kinase JAK Inhibitors Product Information of Teva
Table Astellas Pharma Company Profile
Table Tyrosine Kinase JAK Inhibitors Product Information of Astellas Pharma
Table Celgene Company Profile
Table Tyrosine Kinase JAK Inhibitors Product Information of Celgene
Table CTI BioPharma Company Profile
Table Tyrosine Kinase JAK Inhibitors Product Information of CTI BioPharma
Table Pfizer Company Profile
Table Tyrosine Kinase JAK Inhibitors Product Information of Pfizer
Table Eli Lilly Company Profile
Table Tyrosine Kinase JAK Inhibitors Product Information of Eli Lilly
Figure typical phases from research to the market for a drug candidate
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
Figure Manufacturing Cost Structure of Tyrosine Kinase JAK Inhibitors
Figure Assessment of API Manufacturing Cost By Region
Figure USA Labor Cost Analysis 2012-2016
Figure Cost of Employing a Factory Worker
Figure 2016 Estimated Labour Costs for the Whole Economy in Europe
Figure Monthly Minimum Wages in Asia 2016
Figure China Labor Costs 2013-2016
Table Average Price of Electricity to Ultimate Customers 2007-2016
Figure Electricity Prices for Household Consumers in 2016
Figure Summary of the Driving Assumptions
Figure Industrial Electric Rates 2016 (PER KWH)
Figure Manufacturing Process Analysis of Tyrosine Kinase JAK Inhibitors
Figure Tyrosine Kinase JAK Inhibitors Industrial Chain Analysis
Table Major Buyers of Tyrosine Kinase JAK Inhibitors

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report